Login / Signup

Editorial: a baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients-same score, different outcomes. Author's Reply.

Henry Lik Yuen Chan
Published in: Alimentary pharmacology & therapeutics (2019)
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • hepatitis b virus
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • replacement therapy